Acute cardiac care & resuscitation
Early Implementation of Guideline-Directed Medical Therapy and Outcomes in Cardiogenic Shock Supported by Micro-Axial Flow Pumps
Authors' conclusion
In patients with CS supported by Impella, early GDMT implementation was feasible in a substantial proportion of patients. Greater GDMT exposure at device explantation was associated with lower in-hospital mortality. Ventricular unloading may provide an opportunity to initiate outcome-modifying therapies during the acute phase of CS.
Study context
- Population
- Patients with cardiogenic shock (CS) treated with Impella between 2020 and 2024mean age 61 years, 20% female, 40% received concomitant ECMO (ECPella)
- Participants
- 140 patients
- Exposure
- Number of heart failure therapies administered at device explantation
- Outcome
- In-hospital mortality
Methodological detailsconsecutive patients, multivariable logistic regression, landmark analysis, mixed-effects models
- Consecutive patients
- Multivariable logistic regression
- Landmark analysis
- Mixed-effects models
Main finding
As reported in the abstract
In-hospital mortality
per additional GDMT therapyEstimate (95% CI)P value
Greater GDMT exposure independently associated with lower mortality; multivariable logistic regression
OR 0.28(0.14–0.58)
P < 0.001Landmark analysis excluding patients dying within 5 days
adjusted OR 0.31(0.16–0.66)
P < 0.001After excluding patients with cardiac arrest
adjusted OR 0.48(0.23–0.88)
P = 0.002Per additional GDMT therapy, as printed
- In-hospital mortality (overall)
- 38%
Observational data: associations, not effects.
Further findings
Guideline-directed medical therapy (GDMT) at explantation
- Received at least one GDMT agent
- 43%
GDMT intensity and survival
- A graded relationship between GDMT intensity and survival was observed
Center-level variability
- Intraclass correlation coefficient
- 0.02
Original publication
Early Implementation of Guideline-Directed Medical Therapy and Outcomes in Cardiogenic Shock Supported by Micro-Axial Flow Pumps. Eur J Heart Fail. Published 17 November 2026. doi:10. 1093/ ejhf/ xuag338
Composed by AI from the published abstract and checked against it. How Briefs are made →